Gaultney, Jennifer G. http://orcid.org/0000-0002-3322-1075
Bouvy, Jacoline C.
Chapman, Richard H.
Upton, Alexander J.
Kowal, Stacey
Bokemeyer, Carsten
Solà-Morales, Oriol
Wolf, Jürgen
Briggs, Andrew H.
Funding for this research was provided by:
Bayer Corporation (Medical Writing Support)
Article History
Accepted: 17 April 2021
First Online: 24 May 2021
Declarations
:
: JG and SK received funding for medical writing assistance from Bayer. JC has no funding sources or conflicts of interest to declare. RC has received research grants from Blue Shield of California Foundation, California Healthcare Foundation, Laura and John Arnold Foundation, and NE States Consortium Systems Organization, outside the submitted work; other support received from Aetna, AHIP, Allergan, Alnylam, Anthem, AstraZeneca, Biogen, Blue Shield of California, Boehringer-Ingelheim, Cambia Health Services, CVS, Editas, Express Scripts, Genentech/Roche, GlaxoSmithKline, Harvard Pilgrim Health Care, Health Care Service Corporation, Health Partners, Johnson & Johnson (Janssen), Kaiser Permanente, LEO, Mallinckrodt, Merck, National Pharmaceutical Council, Novartis, Premera, Prime Therapeutics, Regeneron, Sanofi, Spark Therapeutics, and United Healthcare, as dues for annual Policy Summit meeting. AU is an employee of Bayer. CB has received speaking honoraria from Merck KGaA, Sanofi, Roche, Bayer, BMS, AstraZeneca and MSD. CB has received consulting fees from, Lilly, Merck Serono, Sanofi, Bayer, MSD, GSO and AOK Health Insurance. CB has further received research funding from Abbvie, ADC Therapeutics, Agile Therapeutics, Alexion Pharmaceuticals, Amgen, Apellis Pharmaceuticals, AstraZeneca, Bayer, BarGen Bio, Blueprint Medicines, BMS, Boehringer Ingelheim, Celgene, Daiichi Sankyo, Eisai, Gilead, Glycotope, GSK, Incyte, IO Biotech, Isofol Medical, Janssen, Karyopharm Therapeutics, Lilly, Millennium, MSD, Nektar, Novartis, Rafael Pharmaceuticals, Roche, Springworks Therapeutics, and Taiho Pharmaceutical. CB has received travel grants from Merck Serono, Sanofi, Pfizer, and BMS. JW has received advisory board and lecture fees from Amgen, AstraZeneca, Bayer, Blueprint, BMS, Boehringer-Ingelheim, Chugai, Daiichi Sankyo, Ignyta, Janssen, Lilly, Loxo, MSD, Novartis, Pfizer, Roche, Seattle Genetics, and Takeda. JW has received research grants from BMS, Janssen, Novartis, and Pfizer. OSM and AB have received consulting fees, travel grants and speaking honoraria from Bayer.
: All authors were involved in the manuscript conception. JG and SK drafted the article. JB, RC, AU, CB, OSM, JW and AB provided critical revision of the article. All authors provided final approval of the version to be published.